Coronavirus
The US Has Approved Gilead’s Antiviral Drug Remdesivir To Treat Patients With COVID-19
(Reuters) – The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc (GILD.O) for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19, it said in a letter to Gilead.
During a meeting in the Oval Office with President Donald Trump, Gilead Chief Executive Daniel O’Day called the move an important first step and said the company was donating 1.5 million vials of the drug to help patients.
Gilead said on Wednesday the drug had helped improve outcomes for patients with COVID-19, the disease caused by the coronavirus, and provided data suggesting it worked better when given earlier in the course of infection.
The closely watched drug has moved financial markets in recent weeks, following the release of several studies that painted a mixed picture of its effectiveness.
Vice President Mike Pence said the 1.5 million vials would start being distributed to hospitals on Monday.
Kenya Insights allows guest blogging, if you want to be published on Kenya’s most authoritative and accurate blog, have an expose, news TIPS, story angles, human interest stories, drop us an email on [email protected] or via Telegram
Caleb Amisi Says Linda Mwananchi Has Lost Direction, Announces Plans To Form A New Movement
Air Canada Pilot Flew Passengers For Years With A Fake Pilot’s License, Police Say
Itumbi Claims Kalonzo Has Settled on Sifuna as Running Mate
THE KURIA NETWORK TAKES THE BOARDROOM: How Moses Kuria’s Inner Circle Seized Control of Africa Mega Agricorp And the Paper Trail That Links It All
Who Is The Somali Referee Barred From Entering The US For The World Cup?
Inside NCBA’s Decline: How a Banking Giant Lost Its Strategic Edge
Shiquo wa Hii Style Counts Costly Lesson After Anti-Counterfeit Raid Wipes Out Shop Stock
“Are They Giving Kickbacks To Government Officials?” The Scandalous Record Behind Kenya’s Most Favoured Chinese Contractor
Two MPs Defrauded of Sh93.5 Million in Karen Land Scam
Gachagua Rejects Sh50 Million Court Compensation, Calls It An Insult
Cement, Cash and Courts: How the Hashu Dynasty Crushed the Ramji Brothers for Fourteen Years and Why the Walls Are Now Closing In
Inside The Urban Planning Cartel That Owns Nairobi
Why Ruto’s Favourite Candidate Adan Mohammed Could Be Locked Out of the KRA Top Job
LifeCare on the Brink: SHA Fraud, Stolen Wages, and the Rotten Empire Jayesh Saini Built
Este Medical Kenya Fights American’s Explosive Complaints
Betika Faces DCI Probe, Directors Arrest and License Revocation Over Massive 29.5 Million Safaricom Customers’ Data Breach
The Rot Inside Absa: How Bank Insiders Are Looting Nairobi’s Customers
Inside FAFSA Fraud: How Kenyan Cybercriminals Siphoned Millions from America’s Sh12 Billion Student Loan System
Fresh Move Launched to Remove Kenya Railways MD Mainga From Office After Awarding Sh817 Million Consultancy Contract
Court Confirms Safaricom Customers Data Was Sold To Betting Companies In Seven-Year Cover-Up
-
Investigations6 days agoCement, Cash and Courts: How the Hashu Dynasty Crushed the Ramji Brothers for Fourteen Years and Why the Walls Are Now Closing In
-
Investigations5 days agoInside The Urban Planning Cartel That Owns Nairobi
-
Investigations1 week agoBetika Faces DCI Probe, Directors Arrest and License Revocation Over Massive 29.5 Million Safaricom Customers’ Data Breach
-
Investigations6 days agoFresh Move Launched to Remove Kenya Railways MD Mainga From Office After Awarding Sh817 Million Consultancy Contract
-
News2 weeks agoEight Students Arrested In Kenya After Suspected Deadly School Arson Attack
-
News2 weeks agoHow Uhuru’s Deal With Obama In 2015 Paved Way For America’s Ebola Plan In Kenya
-
Business7 days agoTRUST BETRAYED: How Senior DTB Bank Insiders Allegedly Looted Sh149 Million From a Customer’s Account Over Five Years
-
Investigations4 days agoWhy Drivers Cheered Bolt’s Reported Exit: Inside the Slow Financial Strangulation of Thousands of Kenyan Drivers and Riders in Kenya